Aim: To evaluate the effects of dynamized ethyl alcohol (Ethylicum) 6cH and 30cH in mice infected with T. cruzi. Methods: In a blind, randomized and controlled assay, 63 eight-week-old, Swiss, male mice, infected with IP (1400 trypomastigotes, T. cruzi-Y-strain), were allocated into groups: CNI-non-infected (n = 12), CI-infected and non-treated (n = 17), Et 6cH -infected, treated with Ethylicum 6cH (dilution 1:10 12 ) (n = 17), Et 30cH -infected, treated with Ethylicum 30cH (dilution 1:10 60 ) (n = 17).
Introduction
Ethyl alcohol is a substance used worldwide [1] , and is part of many pharmaceutical preparations [2] . Its damaging effects are frequently discussed [3] [4] [5] [6] [7] [8] , but its beneficial effects are not often exploited [9] . Some studies suggest that the light consumption of alcohol seems to be innocuous or even beneficial [10] [11] [12] . When consumed in low to moderate amounts, alcohol relieves anxiety and promotes a feeling of well-being [13] , and promotes a number of other important psychological and social effects [9] . Its moderate consumption is also beneficial in reducing risk of heart and coronary diseases [10] .
This compound is used in homeopathy as a dynamized medication, under the name Ethylicum [14] . According to homeopathic literature, Ethylicum acts predominantly in the digestive tract and the nervous system [14] . Its use may be indicated in cases of insomnia, anorexia, heartburn, nausea, vomiting, diarrhea, and liver and heart disorders [14] . Its overuse can lead to suppression of the immune system [15, 16] . Yet in homeopathy, ethyl alcohol is used in the preparation of medications as an inert ingredient, serving as a vehicle for soluble active ingredients [2, 17] . In these situations, experimental studies demonstrate that the ethyl alcohol does not interfere significantly with the effects of medications [18, 19] .
The use of highly diluted medications has been extensively researched. Studies show that they can promote clinical improvement in several pathologies involving both infectious [20] and non-infectious agents [21, 22] , with proven anatomical, tissue and biochemical positive alterations [23] . In order to study highly diluted medications, our team conducts research using the model of murine infection with the Y strain of T. cruzi. The quantity and quality of articles that exist in the databases show that the already accumulated scientific and technical knowledge [24, 19] makes the experimental murine infection with T. cruzi an excellent study model, with the ability to generate innovations in treatment, such as consideration for the human infection with T. cruzi itself and other parasitic infections, or even to understand the action of highly diluted medications.
Thus, this study aimed to evaluate the effects of potencies 6cH and 30cH of Ethylicum in the course of infection in Swiss mice infected with the Y strain of T. cruzi.
Methodology

Study design
The experiments were blind, controlled and randomized. Sixty-three eight-week-old, Swiss, male mice were used.
The animals were kept in micro-acclimated cages (Alesco® polysulfone cages, 20 cm wide × 32 cm long × 21 cm high). The initial mean weight of the mice in each group did not differ statistically and the animals were maintained in an environment with a controlled temperature (22.7 ± 1.2°C), 12 h/12 h light/dark cycle, with filtered water and food ad libitum.
Infection and experimental groups
The animals were allocated into four experimental groups: CNI -12 non-infected and non-treated animals; CI -17 infected and non-treated animals; Et 6cH -17 infected animals treated with dynamized ethyl alcohol 6cH; and Et 30cH -17 infected animals treated with dynamized ethyl alcohol 30cH. Each group was subdivided into experimental units with 4-5 animals per cage.
The animals were intraperitoneally inoculated with 1400 trypomastigotes of the Y strain of T. cruzi [25] .
Preparation of Ethylicum medication
Ethylicum 6cH and 30cH were prepared as recommended by the Farmacopéia Homeopática Brasileira [17] and Manual de Normas Técnicas [2] . Intermediate dilutions were prepared using ethyl alcohol (CereAlcool®, Brazil) diluted to 70% in sterile water (Sigma-Aldrich®, Germany).
According to the Hahnemann centesimal dilution technique, 0.1 mL of 70% hydrated ethyl grain alcohol was diluted in 9.9 mL of the same alcohol and agitated 100 times in a mechanical dynamizer (DENISE® Brazil). For the following dilutions, 0.1 mL of the previous dilution was used in 9.9 mL of hydrated ethyl grain alcohol (CereAlcool®, Brazil), always dynamizing 100 times for each dilution. This process was repeated until the5cH and 29cH dynamizations were obtained and all the preparations were preserved in commercial amber glass bottles, which were, in the first use, sealed with a stopper and properly identified.
The final test dilutions (Ethylicum 6 cH and 30 cH) were prepared in the same manner as the intermediate solutions, but diluted and dynamized 100 times in 9.9 mL of sterile water (Sigma-Aldrich®, Germany). They were stored in sealed amber bottles and protected from light and heat.
The medications were administered diluted in water (1 mL/100 mL of water) and ad libitum in amber water bottles 48 h before and after the infection, and every 56 h until the 9th day after infection, for 16 uninterrupted hours. This treatment regimen was chosen based on our team's preliminary studies [26, 27] .
Evaluation of the survival time
During the experiment, eight animals from each group were randomly selected and used to evaluate the survival time and mortality. The survival was assessed until day 82 after infection, which is a sufficient time for the organism infecting the mice to respond to the acute phase of the disease, since these animals are very susceptible to the Y strain of T. cruzi [28] .
Survival analysis and estimated lifetime: the lifetime (in days) of the animals after infection was recorded, considering 82 days as the endpoint. Survival was estimated using the Kaplan-Meier method. A graph showing the evolution of survival during the evaluation period and the estimated lifetime was designed by projecting the data obtained from experimental groups for a population. The mortality rate was calculated per group, by the total number of dead animals in relation to the initial total animals in the group, until day 82 after infection.
Measurement of cytokines
Cytokine levels were assessed in serum collected from three animals per group, euthanized at times T0 (before infection), T8 and T12 (8th and 12th days after infection, respectively). Euthanasia was performed with deep anesthesia using ketamine 50 mg/kg and xylazine 10 mg/kg, intraperitoneally [29] . The levels of TNF-α, IL-6, IL-5, IL-10 and IL-17A were measured in 50µL of serum, using the Magnetic Mouse Cytokine 20-Plex Panel Kit (Invitrogen®, USA). The reaction was performed according to the manufacturer's guidelines and the fluorescence was read in Luminex reader (Luminex®200™xPONENT, USA). Concentrations of the cytokines were expressed in picograms/ml and the final results were expressed as mean ± standard deviation of the concentrations obtained from the animals in each group.
Histopathological parameters
The heart collection was carried out after euthanasia on days 0, 8 and 12 after infection (a.i.) as previously described. Heart fragments fixed in 10% formalin for 24 h. In sequence, they were dehydrated and diaphanized to be immersed in paraffin. Histological semi-serial sections (Microtome SLEE MAINZ model CUT 5062-Mainz, Germany) of 5 μm thickness were made, separated by 20 μm intervals and stained with the hematoxylin-eosin technique. The slides were observed using an Olympus BX41 microscope (Tokyo, Japan) and the images were captured with a Qcolor3 camera (Olympus), coupled to the microscope. Ten microscopic fields/section were counted with a 40X objective using an Olympus CBA microscope (Tokyo, Japan), totaling 40 fields/animal.
The histological parameters studied included analysis of the inflammatory infiltrate with the following classification: (1) 
Behavior analysis
We evaluated the behavior of seven animals from each experimental group; one animal at a time was in a circular, "open area" arena, totaling 40 cm diameter, and their behavior was recorded on camera (Sony IR Waterproof Camera, model KD-24S) for a period of five minutes. Videos were analyzed by a trained observer using dedicated software (ANY-maze®). The evaluated parameters were total distance traveled, permanency in central/peripheral area, and immobility.
Statistical analysis
The data obtained were statistically analyzed with Statistica 8.0 and R 3.0.2 software. For survival analysis, an estimation graphic of KaplanMeier and Logrank test was used. The cytokines and behavior data were analyzed using a Mann-Whitney test. The Z test was used for evaluation of inflammation and mortality. The results were expressed as mean ± standard deviations. The level of significance in all the tests was 5%.
Results
Survival analysis
In the analysis of survival, the animals treated with Et 6cH had higher survival (59.9 ± 33.3; p < 0.05) and longer expected survival (12.83 days) compared with the animals in the Et 30cH (26.0 ± 23.6; 6.02 days, respectively) and CI (27.8 ± 22.9; 7.18 days, respectively; Table 1 and Fig. 1 ) groups.
The infection caused a 94.1% mortality rate for the CI group, as well as for the group treated with Et 30cH . In comparison, the group treated with Et 6cH had a 70.6% mortality rate, suggesting a possible benefit with this treatment (Table 1) .
Cytokine levels
In the analysis of cytokines, when we compared the CI group with the CNI group (basal value) we observed that the infection modulates the production of cytokines in an attempt to control the infection (Figs. 2-4) .
During the course of infection (comparison among the evaluated mice on days 0, 8 and 12 after infection), Et 6cH , Et 30cH and CI groups (infected and treated groups) presented serum TNF-α levels significantly higher on days 8 and 12 a.i., when compared with day 0, and on day 12 a.i., when compared with day 8 a.i. (p < 0.05). However, these groups presented different evolutions of serum IL-6 levels. The Et 30cH group exhibited a significant increase in IL-6 concentrations on day 12 a.i., compared with days 0 and 8 (p < 0.05). The Et 6cH group showed a significant increase in IL-6 concentration on days 8 and 12 a.i., compared with day 0, and on day 12 a.i., compared with day 8 a.i. The CI group showed a significant increase in IL-6 concentrations on days 8 a.i. (p < 0.05) and 12a.i. compared with day 0 (Fig. 2 ). On day 0 (before infection), the concentration of pro-inflammatory cytokines TNF-α and IL-6 was significantly higher in the Et 30cH group compared with CI and the basal value (p < 0.05). On day 8 a.i., the Et 30cH group showed a higher concentration of TNF-α compared with CI and the basal value groups and higher concentration of IL-6, compared with the basal value (p < 0.05). However, the Et 6cH group showed higher concentrations of TNF-α and IL-6 only when compared with the basal value (p < 0.05). On day 12 a.i., Et 30cH and Et 6cH groups had higher concentrations of TNF-α and IL-6 compared with CI and basal value groups (p < 0.05).
The infected and treated groups showed the same evolution of serum IL-5 levels (CI, Et 6cH, Et 30cH ) , i.e. they exhibited a significant increase in IL-5 concentrations on days 8 and 12 a.i. compared with day 0 (p < 0.05). Et 30cH and CI groups did not have significantly different IL-10 concentrations during the course of infection. The Et 6cH group presented a significant increase in IL-10 concentrations on day 8 a.i., compared with day 0 (p < 0.05) (Fig. 3) . On day 0, the concentration of anti-inflammatory cytokine IL-5 was significantly higher in the Et 30cH and Et 6cH groups compared with the CI and basal value (p < 0.05). On day 8 a.i., the Et 30cH and Et 6cH groups showed higher concentrations of IL-5 compared with the basal value. Moreover, the Et 30cH group showed a lower concentration of IL-10 compared with CI. On day 12 a.i., the Et 30cH group had a lower concentration of IL-5 compared with the CI group, but this value was significantly higher than the basal value.
The Et 6cH group also had a higher concentration of IL-5 compared with the basal value. On day 12 a.i., it was not possible to detect the concentration of cytokine IL-10 for the different groups (Fig. 3) .
Over the course of the infection, infected and treated groups showed serum IL-17 A levels that were significantly higher on days 8 and 12 a.i., compared with day 0 (p < 0.05). On day 0, the concentration of IL-17 A was significantly lower in the Et 30cH group compared with the CI group (p < 0.05) (Fig. 4) . On day 8 a.i., the Et 30cH group showed a higher concentration of IL-17 A compared with CI and the basal value, while the Et 6cH group had a higher concentration of IL-17 A only when compared with the basal value. On day 12 a.i., Et 30cH and Et 6cH groups showed a higher concentration of IL-17 A compared with the basal value.
The IL-6/IL-5, IL-6/IL-10, TNF-α/IL-5, TNF-α/IL-10 ratios were calculated to evaluate the Th1/Th2 cytokine balance (Fig. 5) . The Et 6cH group showed significant decreases in the IL-6/IL-10 (on day 8 a.i.) and TNF-α/IL-5 (on day 0) ratios, compared with the CI group (p < 0.05) with a more pronounced Th2 response, which was attributable to a significant increase in IL-10 concentrations on day 8 a.i. and IL-5 on day 0. In contrast, the Et 30cH group exhibited significant increases in IL-6/ IL-5 (on days 0 and 12 a.i.), IL-6/IL-10 (on day 0), TNF-α/IL-5 (on days 8 and 12 a.i.) and TNF-α/IL-10 (on day 8 a.i.) ratios compared with the CI group (p < 0.05) with a more pronounced Th1 response. This was attributable to a higher concentration of pro-inflammatory cytokines (IL-6 and TNF-α) than the anti-inflammatory cytokines (IL-5 and IL-10).
Analysis of inflammation
When analyzing the inflammatory process in the heart, we observed that the group treated with Et 6cH had less inflammation than the other infected groups on day 8 a.i (p < 0.05; Figs. 6 and 7A ). This result considers the fact that in the Et 6cH group, most of the fields analyzed had no inflammation and Et 30cH and CI groups had a higher percentage of inflammation of the discreet diffuse and intense diffuse kind, respectively (p < 0.05; Fig. 7B ).
On day 12 a.i., all the infected groups presented with some level of inflammation, however, only the Et 30cH group presented with intense Fig. 1. S (t) estimation, considering 82 days as the endpoint of eight-week-old, Swiss, male mice, intraperitoneally infected with 1400 blood trypomastigotes of the Y strain of T. cruzi and treated with different dynamizations of ethyl alcohol. Groups: CI -infected control; Et 6cH -infected animals treated with Ethylicum 6cH and Et 30cH -Infected animals treated with Ethylicum 30cH. * 100% survival was observed for the CNI group, not included in this graph. Fig. 2 . Serum TNF-α and IL-6 concentrations (pg/ml) on days 0, 8 and 12 after infection, in male Swiss mice, 8 weeks old, intraperitoneally infected with 1400 blood trypomastigotes of the Y strain of T. cruzi untreated or treated with Ethylicum. Groups: CNI -Uninfected control; CI -Infected control; Et 6cH -infected animals treated with Ethylicum 6cH; and Et 30cH -infected animals treated with Ethylicum 30cH.
* significant difference at 5% comparison between days evaluated -0, 8th and 12th. + significant difference at 5% comparison between treated and infected control (CI), at each time. # significant difference at 5% comparison between treated and uninfected control (CNI), at each time. diffuse inflammation (p < 0.05) (Fig. 7) . However, we noticed that although Et 6cH was better than Et 30cH , on day 12 a.i., the CI group were in better condition with more discreet inflammation than the treated groups.
Behavior analysis
Regarding the analysis of the animals' behavior, the CNI group had a significant difference in all evaluated parameters compared with CI, Et 6cH, andEt 30cH groups (p < 0.05) on day 12 a.i., suggesting a better clinical status. However, the animals in the Et 6cH group spent less time in the peripheral zone before infection (p < 0.05) and presented a higher number of episodes of immobility on day 12 a.i compared with the CI group (p < 0.05), confirming its ability to positively interact, which is a good clinical sign and reflects the ability to control the infection with the Ethylicum treatment ( Table 2 ).
Discussion
In our study, we observed that the use of Ethylicum in dynamization 6cH (Et 6cH group) in mice experimentally infected with the Y strain of T. cruzi produced an immunomodulatory action involving increased concentration of IL-5 on day 0 compared with the CI group and the basal value (CNI group). Interestingly, the modulation obtained for these cytokines on day 0 resulted in the action of the medication that was administered before the animal's infection.
The analysis of the Th1/Th2 balance in the Et 6cH group presented significant decreases in ratios of IL-6/IL-10 (on day 8 a.i.) and TNF-α/ IL-5 (on day 0) compared with the CI group (p < 0.05) with a more pronounced Th2 response, which was attributable to a significant increase in IL-10 concentrations on day 8 a.i and IL-5 on day 0. This cytokine balance resulted in decreased inflammation in the heart of the animals on day 8 a.i. compared with the other infected groups, which we think was crucial to the increased survival observed in the animals in the Et 6cH group. In this study, the increase of the anti-inflammatory cytokines was related to decreased inflammation in the cardiac tissue of animals treated with Et 6cH , observed on day 8 after infection compared with the results of the animals from CI and Et 30cH groups. The control of tissue damage caused by TNF-α is performed by immunoregulatory cytokines, such as IL10 and TGF-β, enabling the increase in survival estimation of the infected animals [31] ; therefore, the increase of IL-10 in the Et 6cH group on day 8 was crucial for controlling the inflammatory response, decreasing the inflammation and increasing the host's survival.
Although the sample size of three animals/group for cytokine measures is small, in previous studies performed by our group [23, 32, 33] , we observed that three animals was a sufficient number to statistically evaluate immunological (cytokine measurement) and histological (organ histology, apoptosis evaluation…) parameters in our experimental model and provides information on the trend of variation of these parameters. As we worked with a large number of parameters evaluated (parasitological, clinical, immunological and histopathological), we had to think carefully about the number of animals evaluated per group, which represented the reality of our results producing reliable statistical analysis, and respected the 3Rs principles -Replacement, Reduction and Refinement -imposed by the animal ethics committee at our educational institution. It is important to note that the large number of parameters evaluated provides us a with broad view of what is really happening to the experimental groups, allowing us to confirm consistency between the results obtained for each parameter, which ensures that three animals are sufficient for the size of samples for cytokine measurement.
Ethyl alcohol, when moderately consumed, reduces the risk of heart and coronary diseases [10] . Moreover, alcohol is believed to have a protective effect against the development of these diseases [34] by increasing HDL-c (High Density Lipoproteins-c), reducing fibrinogen [35, 36] , lowering blood pressure [37] , and improving lipid levels in the blood, coagulation and clot lysis, among other benefits [38] . In our study model, we observed these anti-inflammatory and protective effects of ethyl alcohol in the heart when highly diluted medications were administered (Ethylicum). Although the control of inflammation had not persisted on day 12 after infection, it directly influenced the increased survival of the animals in the Et 6cH group. In this experimental model, the majority of the animals die if not treated, due to the high virulence of the Y strain of T. cruzi and the high susceptibility of the lineage of mice used [39] .
The use of Ethylicum 30cH in mice experimentally infected with the Y strain of T. cruzi also produced an immunomodulatory action that was different from that produced by the Ethylicum 6cH and the infection control. The immune response involved significantly increased TNF-α concentrations on days 8 and 12 a.i., and IL-6 on days 0 and 12 a.i. compared with the CI group and the basal value. Higher concentrations of the pro-inflammatory cytokines led the Et 30cH group to present with significant increases in ratios of IL-6/IL-5 (on days 0 and 12 a.i.), IL-6/ IL-10 (on day 0), TNF-α/IL-5 (on days 8 and 12 a.i.) and TNF-α/IL-10 (on day 8 a.i.), compared to the CI group, with a more pronounced Th1 response, which is involved with the protection against acute infection with T. cruzi [40] [41] [42] . However, the high concentration of proinflammatory cytokines before the infection might be extremely harmful to the host because of their toxic effects [43] [44] [45] , increasing the inflammation in this group.
In many infectious diseases, the main pathological aspects are not related to a direct action of the aggressor agent, but are related to an abnormal immune response, in which there is a hypersensitivity reaction with exaggerated and unmodulated immune response and resulting in tissue damage [47, 48] . In various protozoan diseases, there is evidence that the exacerbated immune response is involved in tissue damage, with massive production of TNF-α and NO, as documented in the pathogenesis of cerebral malaria [49] . In our study, we also observed that excessive pro-inflammatory response is harmful, with increased inflammatory processes in the cardiac tissue of the animals infected and treated with Ethylicum 30cH.
Ferraz et al. [32] observed another situation, evaluating the effects of biotherapies (homeopathics prepared from rabbit serum) in Swiss mice experimentally infected with T. cruzi. The group with the best outcome in their study, expressed as decreases in blood parasitemia and parasite load/inflammation in the heart, displayed a more pronounced Th1 response, due to the decrease in IL-4 concentrations without significant increases in TNF-α and IFN-γ, leading to a beneficial response, in contrast with the effect observed in Et 30cH .
However, in infections caused by intracellular agents, a deviated immune response towards the Th2 pole is harmful because it increases susceptibility to infection and allows the multiplication and spread of the parasite; the concept that a strong Th1 response is protective should be viewed with caution [46] . Balanced activity of the immune system is very important to contain the parasite without tissue destruction so that, despite remaining, the infecting agent does not cause disease in animals. The balance between Th1 and Th2 response is influenced by several factors, such as the local cytokine profile. In the model used, Th2 response regulates Th1 response, and therefore, when dysregulated, it may increase tissue inflammation.
Also, for the control of parasitism, the immune response relies on the action of IL-17A. This cytokine plays a significant role in inflammation by regulating the expression of various inflammatory mediators, including IL1-β, chemokines, and adhesion molecules [50] . The Th17 response has been linked to the pathogenesis of several inflammatory/autoimmune diseases [51] and some infectious diseases [52, 53] . However, the pathogenic or protective role of the Th17 response in mice or humans infected with T. cruzi is still controversial [54] [55] [56] [57] [58] . Magalhães et al. [55] correlated lower expression of IL-17 A with worse cardiac function in human Chagas disease, while Da Matta Guedes et al. demonstrated increased inflammation in the heart and early mortality in mice [56] . Our data demonstrate that during the course of the infection, the treated groups (Et 6cH, Et 30cH ) had higher concentrations of IL-17A on day 8 and 12 a.i. However, the Et 30cH group showed lower concentrations of IL-17A on day 0, which could lead to the increased inflammation in the heart on day 12 a.i., demonstrating that the modulation of the immune system before the infection was important to determine the evolution of the infection with T. cruzi [59] .
In addition, when analyzing the behavior of animals treated with the Et 6cH medication before infection, we observed that, although the total distance traveled in the assessed time is the same compared with the other groups, these treated animals spent less time in the peripheral zone (p < 0.05). This allowed for decreased anxiety and increased welfare of the animals in the new environment [60] , which is in agreement with literature describing the anxiolytic action of alcohol with positive effects on social behavior [13, 9] .The different behavior extended over the course of infection and on day 12 after infection, shorter periods of immobility are observed. Considering that the infection with the Y strain causes debility in infected animals [60] , this finding shows that the treatment with Ethylicum leads to less debility.
Acute infections, such as the studied model, should be treated with homeopathic medications in low dynamization [61] . This information may be relevant to understanding the different effects caused by the dynamizations 6cH and 30cH of alcohol using the same treatment regimen. The data obtained in this study corroborates this information, in which the lower dynamization provided better results in this experimental model because it is an acute and severe infection [62] . This situation was observed in previous studies performed by our team using the same model [20, 21, 26] .
It is also important to consider that the treatment regimen used, with a dose before the infection, prepares the organism to fight against the disease [20] . Therefore, to achieve the re-establishment of the animal's health, we need to have an appropriate number of doses and a suitable treatment regimen to determine the process of returning to health [21, 63, 64, 65] . Changing the treatment regimen with more frequent doses could improve the results [61] .
Offering homeopathic medication along with water or food is another interesting point to be discussed and it is a common practice [27, 66, 67] . In our group, the standardization of the treatment offered orally with drinking water was established in an earlier study published by our group using the same experimental model [27] . In this study, Aleixo et al. demonstrated that the treatment given orally with drinking water was more beneficial than the oral treatment with gavage (0.2 ml/ animal). In homeopathy, the dosage of the medication is not measured in concentration, but by the amount of stimuli [68, 69] . The administration of the medication diluted in water or salt [66, 67] provides a greater amount of stimuli (i.e., the medication was consumed by the animals each time they drank water, providing them a medication stimulus), consistent with the physiological needs of the animals, in addition to not incorporating major stresses in the experimental protocol. Gavage treatment, besides causing stress due to the way it is administered, with the introduction of cannula orally (interfering in the immunological balance), provides less stimuli.
In homeopathy, it is common to question the dosage of the active principle in the medication or in the blood of the animals of the experimental groups. Although at dynamization 6cH the concentration can be measured, at 30cH there is no equipment capable of detecting molecules of the compound due to the high dilution, since the dilution was made beyond the Avogadro number (6.022 × 10 23 molecules per mole of a substance) [70] . We consider the approach of demonstrating the medication in the blood as a further perspective for the lower dynamizations. The data presented demonstrate that the Ethyl alcohol induces the production of cytokines that, acting synergistically, can balance the organism, ensuring benefits with increased survival. These cytokines can produce toxic effects from the exacerbated concentrations as well as a lack of effects from insufficient concentrations, which can lead to different developments over the course of the infection. Similarly, an adequate treatment regimen and dynamization leads to a balanced production of these cytokines, which benefits the treated organism. The results draw attention not only to the effects of the substance ethyl alcohol, which is considered an inert vehicle for the preparation of homeopathic medications, but also to the right choice of the dynamization used, confirming that administration of low dynamizations of homeopathic preparations is the most appropriate in acute infections. The data obtained in this study raises the expectancy of using alternative treatments for management of Chagas disease, which is considered a neglected disease, resulting in Brazil having only one allopathic medication (benznidazole) for its etiological treatment. In this context, homeopathy has proven to be an important instrument in controlling the progression of disease.
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